Free Trial

AEON Biopharma (AEON) SEC Filings & 10K Form

AEON Biopharma logo
$0.77 +0.08 (+11.58%)
Closing price 04:00 PM Eastern
Extended Trading
$0.76 -0.01 (-1.16%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AEON Biopharma SEC Filings

DateFilerForm TypeView
07/09/2025
11:33 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G/A
06/11/2025
5:04 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEFR14A
05/30/2025
11:10 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Chernett Jorey (Filed by)
Form SCHEDULE 13G
05/23/2025
3:55 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:56 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:57 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:04 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:46 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:51 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
3:50 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:21 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
5:35 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
6:07 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
04/29/2025
3:10 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form ARS
04/21/2025
3:11 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:02 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:45 AM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G
03/10/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
12:51 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Dauntless Investment Group, LLC (Filed by)
Form SCHEDULE 13G
02/24/2025
1:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:44 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:45 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEF 14A
01/22/2025
3:02 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
Form SCHEDULE 13D
01/13/2025
3:08 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
3:14 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form PRE 14A
01/08/2025
3:15 PM
AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
01/07/2025
3:05 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:04 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
01/06/2025
8:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:00 AM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
11/13/2024
3:06 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:07 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:08 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
10/07/2024
4:01 PM
AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
8:04 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4/A
09/04/2024
8:52 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:53 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.tc pixel

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:59 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:49 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM
AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AEON) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners